Irbesartan Eg (Irbesartan)

Irbesartan works by selectively blocking angiotensin II type 1 (AT1) receptors. This prevents angiotensin II from causing vasoconstriction and aldosterone release, leading to vessel relaxation, reduced sodium and water retention, lower blood pressure, and decreased pressure within the kidney’s filtering units.

The appropriate dose of Irbesartan is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Irbesartan is generally not recommended for use during pregnancy because it may affect fetal kidney development. Safety during breastfeeding has not been established, so a healthcare provider should be consulted before use in nursing mothers.

To order Irbesartan Eg, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Irbesartan belongs to the ARB class, which blocks the effects of angiotensin II without affecting bradykinin levels, unlike ACE inhibitors. Compared with calcium‑channel blockers or diuretics, ARBs are often better tolerated with fewer cough or electrolyte disturbances, making them a common choice for patients who cannot use ACE inhibitors.

Irbesartan tablets should be stored at ambient temperature, preferably below 25 °C, in their original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Irbesartan is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious risks include hyperkalemia (high potassium levels), acute kidney injury, and angioedema (swelling of the face, lips, tongue, or airway). Patients should seek immediate medical attention if they experience swelling, severe dizziness, or signs of kidney dysfunction such as reduced urine output.

Irbesartan should not be used by individuals with known hypersensitivity to Irbesartan or any other ARB, and it is contraindicated in patients with severe hepatic impairment. Caution is also advised for those with bilateral renal artery stenosis or pregnant women.